CRLCHARLES RIVER LABORATORIES
CUSIP 159864107 · common stock
7 tracked investors held CHARLES RIVER LABORATORIES (CRL) at the end of Q3 2026, worth $986.1M in total. The largest holder was Bill Nygren, with 0.5% of its portfolio. Ron Baron opened a new position this quarter.
Holders · Q3 2026
7
New holders
1
Value held
$986.1M
Quarter-end price (est.)
$295.01
Investors holding CRL · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Bill Nygren Harris Associates L.P. (Oakmark) | 0.54% | 1,410,332 | $416.1M | REDUCE-37.1% |
| John Rogers Ariel Investments, LLC | 3.66% | 1,193,348 | $352M | REDUCE-20.8% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.24% | 412,625 | $121.7M | REDUCE-4.7% |
| PRIMECAP Management PRIMECAP Management Co | 0.05% | 266,850 | $78.7M | REDUCE0.0% |
| Ron Baron BAMCO Inc. (Baron Capital) | 0.03% | 52,027 | $15.3M | NEW |
| Murray Stahl Horizon Kinetics Asset Management LLC | 0.02% | 6,444 | $1.9M | REDUCE-9.3% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 955 | $281.8K | REDUCE-4.7% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.48% | 140,000 | $31.8M | EXIT |